Schedule 13D ownership disclosure
Soleno Therapeutics Inc
Security class unavailable · CUSIP: 834203309
Event date: 2024-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-261952
- Form type
- SC 13D
- Filer
- PERCEPTIVE ADVISORS LLC
- CIK
- CIK 1224962
- Filed
- Nov 19, 2024
- Reporting period
- Nov 14, 2024
- Description
- Schedule 13D beneficial ownership